LGND logo

LGND Total expenses

Annual total expenses:

$144.11M+$22.62M(+18.62%)
December 31, 2024

Summary

  • As of today (June 4, 2025), LGND annual total expenses is $144.11 million, with the most recent change of +$22.62 million (+18.62%) on December 31, 2024.
  • During the last 3 years, LGND annual total expenses has risen by +$6.42 million (+4.66%).
  • LGND annual total expenses is now -25.41% below its all-time high of $193.21 million, reached on December 31, 2022.

Performance

LGND Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Quarterly total expenses:

$81.99M+$40.87M(+99.37%)
March 31, 2025

Summary

  • As of today (June 4, 2025), LGND quarterly total expenses is $81.99 million, with the most recent change of +$40.87 million (+99.37%) on March 31, 2025.
  • Over the past year, LGND quarterly total expenses has increased by +$54.00 million (+192.93%).
  • LGND quarterly total expenses is now at all-time high.

Performance

LGND Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

LGND Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.6%+192.9%
3 y3 years+4.7%+138.5%
5 y5 years+14.4%+179.1%

LGND Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.4%+18.6%at high+192.9%
5 y5-year-25.4%+18.6%at high>+9999.0%
alltimeall time-25.4%+383.9%at high+253.2%

LGND Total expenses History

DateAnnualQuarterly
Mar 2025
-
$81.99M(+99.4%)
Dec 2024
$144.11M(+18.6%)
$41.13M(+0.7%)
Sep 2024
-
$40.86M(+19.7%)
Jun 2024
-
$34.14M(+22.0%)
Mar 2024
-
$27.99M(-11.0%)
Dec 2023
$121.49M(-37.1%)
$31.46M(-1.4%)
Sep 2023
-
$31.91M(+12.6%)
Jun 2023
-
$28.35M(-4.8%)
Mar 2023
-
$29.77M(-57.8%)
Dec 2022
$193.21M(+40.3%)
$70.48M(+50.3%)
Sep 2022
-
$46.88M(+13.1%)
Jun 2022
-
$41.46M(+20.6%)
Mar 2022
-
$34.38M(-4365.9%)
Dec 2021
$137.69M(-3.8%)
-$806.00K(-101.6%)
Sep 2021
-
$49.13M(+26.2%)
Jun 2021
-
$38.94M(-22.8%)
Mar 2021
-
$50.44M(+21.9%)
Dec 2020
$143.18M(+13.6%)
$41.38M(+8.6%)
Sep 2020
-
$38.10M(+11.0%)
Jun 2020
-
$34.32M(+16.8%)
Mar 2020
-
$29.37M(-21.0%)
Dec 2019
$126.00M(+43.6%)
$37.18M(+24.1%)
Sep 2019
-
$29.97M(+2.9%)
Jun 2019
-
$29.12M(-2.1%)
Mar 2019
-
$29.74M(+12.5%)
Dec 2018
$87.73M(+20.1%)
$26.44M(+18.6%)
Sep 2018
-
$22.30M(+12.2%)
Jun 2018
-
$19.87M(+3.9%)
Mar 2018
-
$19.12M(-13.6%)
Dec 2017
$73.03M(+12.2%)
$22.11M(+31.0%)
Sep 2017
-
$16.88M(+12.7%)
Jun 2017
-
$14.98M(-21.4%)
Mar 2017
-
$19.05M(+1.2%)
Dec 2016
$65.09M(+46.0%)
$18.83M(+16.6%)
Sep 2016
-
$16.15M(+3.9%)
Jun 2016
-
$15.55M(+6.9%)
Mar 2016
-
$14.55M(+32.7%)
Dec 2015
$44.59M(+1.7%)
$10.96M(+25.2%)
Sep 2015
-
$8.76M(-36.7%)
Jun 2015
-
$13.84M(+25.4%)
Mar 2015
-
$11.03M(-13.8%)
Dec 2014
$43.83M(+32.9%)
$12.80M(+13.7%)
Sep 2014
-
$11.26M(+23.5%)
Jun 2014
-
$9.11M(-14.5%)
Mar 2014
-
$10.65M(+31.4%)
Dec 2013
$32.99M(+9.3%)
$8.11M(-16.5%)
Sep 2013
-
$9.71M(+28.7%)
Jun 2013
-
$7.54M(-1.2%)
Mar 2013
-
$7.63M(-15.3%)
Dec 2012
$30.17M(+1.3%)
$9.01M(+17.9%)
Sep 2012
-
$7.64M(+6.9%)
Jun 2012
-
$7.14M(+11.8%)
Mar 2012
-
$6.39M(-19.9%)
Dec 2011
$29.78M(-14.7%)
$7.98M(+11.8%)
Sep 2011
-
$7.14M(-18.1%)
Jun 2011
-
$8.71M(+46.3%)
Mar 2011
-
$5.96M(-163.9%)
Dec 2010
$34.90M(-50.4%)
-$9.32M(-139.0%)
Sep 2010
-
$23.90M(+141.6%)
Jun 2010
-
$9.89M(-5.0%)
Mar 2010
-
$10.41M(-69.9%)
Dec 2009
$70.32M
$34.57M(+385.1%)
DateAnnualQuarterly
Sep 2009
-
$7.13M(-39.7%)
Jun 2009
-
$11.81M(-31.7%)
Mar 2009
-
$17.28M(+9.8%)
Dec 2008
$54.55M(-27.3%)
$15.74M(+35.7%)
Sep 2008
-
$11.60M(+11.2%)
Jun 2008
-
$10.44M(-39.5%)
Mar 2008
-
$17.26M(+9.4%)
Dec 2007
$75.03M(-8.6%)
$15.78M(+11.1%)
Sep 2007
-
$14.20M(-10.0%)
Jun 2007
-
$15.78M(-46.1%)
Mar 2007
-
$29.28M(+25.9%)
Dec 2006
$82.06M(+52.4%)
$23.26M(+3.6%)
Sep 2006
-
$22.45M(+17.4%)
Jun 2006
-
$19.12M(+11.0%)
Mar 2006
-
$17.23M(-132.2%)
Dec 2005
$53.84M(-57.8%)
-$53.53M(-246.3%)
Sep 2005
-
$36.59M(-30.0%)
Jun 2005
-
$52.31M(-0.9%)
Mar 2005
-
$52.76M(-331.5%)
Dec 2004
$127.49M(-17.8%)
-$22.78M(-147.9%)
Sep 2004
-
$47.54M(-7.5%)
Jun 2004
-
$51.40M(-32.8%)
Mar 2004
-
$76.50M(+83.1%)
Dec 2003
$155.13M(+34.2%)
$41.77M(+5.8%)
Sep 2003
-
$39.48M(+3.4%)
Jun 2003
-
$38.20M(+7.0%)
Mar 2003
-
$35.69M(+28.8%)
Dec 2002
$115.62M(+16.2%)
$27.70M(-13.6%)
Sep 2002
-
$32.05M(+11.9%)
Jun 2002
-
$28.64M(+5.2%)
Mar 2002
-
$27.23M(+8.1%)
Dec 2001
$99.48M(+5.8%)
$25.19M(+6.1%)
Sep 2001
-
$23.73M(-5.6%)
Jun 2001
-
$25.15M(-1.0%)
Mar 2001
-
$25.40M(+9.3%)
Dec 2000
$93.99M(-8.0%)
$23.25M(-3.3%)
Sep 2000
-
$24.03M(-1.3%)
Jun 2000
-
$24.35M(+8.8%)
Mar 2000
-
$22.37M(-23.1%)
Dec 1999
$102.19M(+17.1%)
$29.09M(+16.8%)
Sep 1999
-
$24.90M(-1.2%)
Jun 1999
-
$25.20M(+9.6%)
Mar 1999
-
$23.00M(-18.4%)
Dec 1998
$87.30M(+5.8%)
$28.20M(+35.6%)
Sep 1998
-
$20.80M(+1.0%)
Jun 1998
-
$20.60M(+16.4%)
Mar 1998
-
$17.70M(-25.3%)
Dec 1997
$82.50M(+18.4%)
$23.70M(+15.6%)
Sep 1997
-
$20.50M(+6.2%)
Jun 1997
-
$19.30M(+2.1%)
Mar 1997
-
$18.90M(-6.4%)
Dec 1996
$69.70M(+41.1%)
$20.20M(+18.1%)
Sep 1996
-
$17.10M(-1.7%)
Jun 1996
-
$17.40M(+16.8%)
Mar 1996
-
$14.90M(-2.6%)
Dec 1995
$49.40M(+44.4%)
$15.30M(+7.0%)
Sep 1995
-
$14.30M(+64.4%)
Mar 1995
-
$8.70M(-9.4%)
Dec 1994
$34.20M
$9.60M(+12.9%)
Sep 1994
-
$8.50M(+3.7%)
Jun 1994
-
$8.20M(+3.8%)
Mar 1994
-
$7.90M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual total expenses?
  • What is the all time high annual total expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual total expenses year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly total expenses?
  • What is the all time high quarterly total expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly total expenses year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual total expenses?

The current annual total expenses of LGND is $144.11M

What is the all time high annual total expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual total expenses is $193.21M

What is Ligand Pharmaceuticals Incorporated annual total expenses year-on-year change?

Over the past year, LGND annual total expenses has changed by +$22.62M (+18.62%)

What is Ligand Pharmaceuticals Incorporated quarterly total expenses?

The current quarterly total expenses of LGND is $81.99M

What is the all time high quarterly total expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly total expenses is $81.99M

What is Ligand Pharmaceuticals Incorporated quarterly total expenses year-on-year change?

Over the past year, LGND quarterly total expenses has changed by +$54.00M (+192.93%)
On this page